- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hodgkin´s Lymphomas in United States
Total 5070 results
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Kronos BioRecruitingNon-Hodgkin Lymphoma | Refractory Solid Tumors | Relapsed Solid TumorsUnited States, Spain, United Kingdom
-
Corixa CorporationUnknownNon-Hodgkin's LymphomaUnited States
-
TakedaActive, not recruitingHodgkin DiseaseUnited States, Italy, Brazil, Japan
-
GlaxoSmithKlineCompletedLymphoma, Non-HodgkinUnited States, France, United Kingdom
-
University of ChicagoCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Classical Hodgkin Lymphoma | B-cell Non-Hodgkin LymphomaUnited States
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
University of WashingtonNational Cancer Institute (NCI); Seagen Inc.Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedEverolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedLymphoma | Solid TumorsUnited States
-
Weill Medical College of Cornell UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Waldenstrom... and other conditionsUnited States
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States
-
M.D. Anderson Cancer CenterCompletedAcute Myeloid Leukemia | Leukemia | Multiple Myeloma | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Non-Hodgkins Lymphoma | Myeloproliferative Diseases | Hodgkins LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
Adnexus, A Bristol-Myers Squibb R&D CompanyCompletedCancerUnited States
-
Genta IncorporatedCompletedNon-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade LymphomaUnited States
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedLymphoma, FollicularUnited States
-
Roncarolo, Maria Grazia, MDNational Cancer Institute (NCI)RecruitingHodgkin's Lymphoma | MDS (Myelodysplastic Syndrome) | ALL | Mixed Phenotype Acute Leukemia | AML - Acute Myeloid Leukemia | NHL - Non-Hodgkin's LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingLymphocyte-Rich Classical Hodgkin Lymphoma | Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma | Recurrent Mixed Cellularity Classical Hodgkin Lymphoma | Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma | Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma | Refractory Mixed... and other conditionsUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Northwestern UniversityRobert H. Lurie Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
University of PennsylvaniaKite, A Gilead CompanyRecruiting
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Eisai Inc.CompletedNon-Hodgkin's Lymphoma | Lymphoma, B-cell | Lymphoma, Low-gradeUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma and other conditionsUnited States
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Kenya, Uganda
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
NYU Langone HealthMerck Sharp & Dohme LLCTerminatedRelapsed Non-Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States
-
St. Jude Children's Research HospitalCompletedLymphoblastic LymphomaUnited States
-
Beth Israel Deaconess Medical CenterTerminated
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Small Intestine Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage III Mycosis... and other conditionsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma and other conditionsUnited States
-
Ascenta TherapeuticsCompletedFollicular LymphomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Myelofibrosis | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Lymphoid Malignancies | Relapsed Non-Hodgkin Lymphoma and other conditionsUnited States
-
New York Medical CollegeJohns Hopkins University; M.D. Anderson Cancer Center; Baylor College of Medicine and other collaboratorsTerminated
-
Emory UniversityNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Northwestern UniversityAmgenTerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IA Mycosis Fungoides/Sezary Syndrome | Stage... and other conditionsUnited States
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Corixa CorporationGlaxoSmithKlineUnknownNon-Hodgkin's LymphomaUnited Kingdom, United States
-
TularikTerminatedNon-Hodgkin's LymphomaUnited States